Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient.
Zygoascus hellenicus (Candida hellenica) was isolated from a blood culture from a patient who had received an allogeneic stem cell transplant. The isolate displayed an antifungal susceptibility pattern of decreased susceptibility to fluconazole and itraconazole, high susceptibility to voriconazole, and low susceptibility to caspofungin. The organism was misidentified by a commercial yeast identification system. This is the first reported case of human infection with this rare ascomycetous yeast.
Brandt
Mary E
ME
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd., Mailstop G-11, Atlanta, GA 30333, USA. mbb4@cdc.gov
Kauffman
Carol A
CA
Pappas
Peter G
PG
Iqbal
Naureen
N
Arthington-Skaggs
Beth A
BA
Lee-Yang
Wendy
W
Smith
Maudy T
MT
D001483:Base Sequence; D002175:Candida / Q000187:drug effects / Q000302:isolation & purification*; D016469:Fungemia / Q000209:etiology*; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D008969:Molecular Sequence Data; D033581:Stem Cell Transplantation / Q000009:adverse effects*; D014184:Transplantation, Homologous